PHYSICIANS

11 of 11 resultsNews

  • US study says colorectal cancer screening practices need improvement

    A Centers for Disease Control and Prevention (CDC) study has found that current screening methods for colorectal cancer using the fecal occult blood tests (FOBT) are often not the appropriate choice of test.

    17/05/2010

  • Ortho gains FDA approval for HIV testing

    ORTHO CLINICAL Diagnostics has received the FDA's approval for a diagnostic assay for the detection of antibodies to human immunodeficiency virus types 1+2 for use on the Vitros 5600 integrated and Vitros 3600 immunodiagnostic systems.

    16/10/2009

  • AACC Annual Meeting and Expo a success

    developments in laboratory medicine and attracted over 18,000 physicians, scientists and others involved in laboratory medicine in hospitals, universities, and private laboratories.

    17/08/2009

  • Victorian infection control state conference

    THE VICTORIAN Infection Control Professionals Association has announced its Biennial State Conference to be held at the Grand Hyatt, Melbourne on 7 to 9 October 2009.

    31/08/2009

  • Raptiva suspended in European market

    Raptiva suspended in European market

    THE EUROPEAN Medicines Agency (EMEA) has recommended to the European Commission the suspension of the marketing authorization for a Merck therapy.

    20/02/2009

  • PerkinElmer and ID Biological Systems join forces

    PerkinElmer and ID Biological Systems join forces

    PERKINELMER has announced it has entered into a contract with ID Biological Systems to become its exclusive worldwide distributer for specimen collection cards used by newborn screening programs worldwide.

    29/04/2009

  • Allergan receives FDA approval for cataract drug Acuvail

    ALLERGAN has announced it has received approval from the United States Food and Drug Administration (FDA) for Acuvail (ketorolac tromethamine ophthalmic solution).

    28/07/2009

  • Rebranded MS treatment available

    Rebranded MS treatment available

    NOVARTIS has launched Extavia, a rebranded version of the standard-of-care treatment for relapsing forms of multiple sclerosis (MS).

    28/01/2009

  • Dr Neil Frazer heads to the US for vaccine trials

    Dr Neil Frazer, Prima BioMed's Chief Medical Officer will oversee clinical trials in the US for the company's CVac ovarian cancer vaccine treatment.

    27/11/2009

  • Luminex Cystic Fibrosis test receives FDA clearance

    LUMINEX has announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new cystic fibrosis (CF) test, the xTAG Cystic Fibrosis 39 Kit v2.

    07/09/2009

  • PerkinElmer secures clearance for newborn screening platform

    PerkinElmer has received 510K clearance from the US Food and Drug Administration (FDA) for its GSP™ Genetic Screening Processor, which is used by public health laboratories worldwide as part of newborn screening programs.

    04/11/2009

 

4 of 4 resultsProducts

     

    Find more information about physicians on our other sites.

    to get Clinical Lab
    delivered to your inbox

    Latest from Twitter

      Getting your tweets...